BackgroundCheck.run
Search For

Yuan ChangBrooklyn, NY

Related to:
Grace C Chang 50 Susan Chang Cho 48 Susan Chang Lanyun Chang 45

Yuan Chang Phones & Addresses

Brooklyn, NY   

Cambridge, MA   

New York, NY   

101 W End Ave APT 6T, New York, NY 10023    917-4418756   

Get Report
Control this profile

Mentions for Yuan Chang

Career records & work history

Medicine Doctors

Yuan Chang Photo 1

Yuan Wen Chang

Specialties:
Pathology
Education:
National Taiwan University (1970)

License Records

Medical Doctor

Address:
630 W 168 St, New York, NY 10032
Licenses:
License #: 31516 - Expired
Issued Date: Feb 14, 1992
Renew Date: May 31, 1993
Expiration Date: May 31, 1993
Type: Physician

Yuan Chang resumes & CV records

Resumes

Yuan Chang Photo 42

Senior Administrator

Industry:
Semiconductors
Work:
UMC
Senior administrator
Education:
National Chiao Tung University
Master of Science, Masters
Yuan Chang Photo 43

Yuan Lung Chang

Yuan Chang Photo 44

Yuan Chang

Yuan Chang Photo 45

Yuan Chi Chang

Yuan Chang Photo 46

Postdoctoral Research Fellow At Northwestern University

Position:
Postdoctoral Research Fellow at Northwestern University
Location:
Evanston, Illinois
Industry:
Research
Work:
Northwestern University - Evanston, IL since Aug 2012
Postdoctoral Research Fellow University of Florida - Gainesville, Florida Area Aug 2008 - Aug 2012
Teaching/Research Assistant
Education:
University of Florida
Doctor of Philosophy (Ph.D.), Design, Construction and Planning Harbin Institute of Technology
Doctor of Philosophy (Ph.D.), Management Science and Engineering Beijing Institute of Civil Engineering and Architecture
Master of Science (M.S.), Construction Engineering and Management
Interests:
LCA, Energy and environmental system sustainability
Yuan Chang Photo 47

Loan Operations At Romasia Bank

Location:
Greater New York City Area
Industry:
Financial Services

Publications & IP owners

Us Patents

Unique Associated Kaposis Sarcoma Virus Sequences And Uses Thereof

US Patent:
6348586, Feb 19, 2002
Filed:
Nov 17, 1999
Appl. No.:
09/230371
Inventors:
Yuan Chang - Irvington NY
Roy A. Bohenzky - Mountain View CA
James J. Russo - New York NY
Isidore S. Edelman - New York NY
Patrick S. Moore - Irvington NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 39245
US Classification:
536 2372, 4242311, 4241861, 4242291, 435325, 4353201, 4352351, 435 6, 514 44, 536 231, 536 241, 536 2432, 536 2433, 530350
Abstract:
This invention provides an isolated nucleic acid molecule which encodes Kaposis Sarcoma-Associated Herpesvirus (KSHV) polypeptides. This invention provides an isolated polypeptide molecule of KSHV. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine for Kaposis Sarcoma (KS). This invention provides methods of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and of detecting expression of a DNA virus associated with Kaposis sarcoma in a cell.

Unique Associated Kaposis Sarcoma Virus Sequences And Uses Thereof

US Patent:
6500663, Dec 31, 2002
Filed:
Mar 6, 2000
Appl. No.:
09/519489
Inventors:
Yuan Chang - New York NY
Patrick S. Moore - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C12N 700
US Classification:
4352351, 435 71, 435325, 4353722, 4242291, 4242301, 536 2372
Abstract:
This invention provides an isolated DNA molecule which is at least 30 nucleotides in length and which uniquely defines a herpesvirus associated with Kaposis sarcoma. This invention provides an isolated herpesvirus associated with Kaposis sarcoma. This invention provides an isolated peptide encoded by the isolated DNA molecule. Further, this invention provides an isolated DNA virus wherein the viral DNA is about 270 kb in size; wherein the DNA encodes a thymidine kinase; and wherein the viral DNA is capable of selectively hybridizing to a nucleic acid probe selected from the group consisting of SEQ. ID NOs:10-12. This invention provides an antibody specific to the peptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a transgenic nonhuman mammal and a cell line containing at least a portion of the isolated DNA molecule. This invention provides a method of vaccinating a subject for KS, prophylaxis diagnosing or treating a subject with KS and detecting expression of a DNA virus associated with Kaposis sarcoma in a cell.

Immunogenic Determinant For Use In The Diagnosis Of Kaposis Sarcoma

US Patent:
6605425, Aug 12, 2003
Filed:
Mar 15, 2000
Appl. No.:
09/254592
Inventors:
Thomas Friedrich Schulz - Wirral LGO ODU, DE
Patrick S. Moore - Irvington NY, 10533
Guy R. Simpson - Surrey KT6 5PQ, GB
Yuan Chang - Irvington NY, 10533
International Classification:
C12Q 170
US Classification:
435 5, 435 792, 530300
Abstract:
The present invention relates to an immunogenic determinant. More particularly, it relates to a protein or a protein fragment for use in the diagnosis of Kaposis sarcoma or human herpesvirus 8 (KSHV/HHV8) and to a diagnostic kit utilising the protein or protein fragment of the invention. The amino acid sequence of the carboxyterminal end of KSHV orf 65 is given below: Sequence 1: Amino acids 86-170 of KSHV orf 65. ADRVSAASY DAGTFTVPSR PGPASGTTPG GQDSLGVSGS SITTLSSGPH SLSPASDILT TLSSTTETTA PAVADARKPP SGKKK.

Spliced Gene Of Kshv / Hhv8, Its Promoter And Monoclonal Antibodies Specific For Lana2

US Patent:
6653465, Nov 25, 2003
Filed:
Dec 8, 2000
Appl. No.:
09/733728
Inventors:
Yuan Chang - Irvington NY
Patrick S. Moore - Irvington NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07H 2104
US Classification:
536 241, 4242291, 4241991, 435 911, 435325
Abstract:
This invention provides an isolated nucleic acid which encodes a Kaposis sarcoma-associated herpesvirus latency-associated nuclear antigen 2 polypeptide (LANA2) or a fragment thereof and also provides the LANA2 polypeptide. This invention provides an isolated nucleic acid comprising consecutive nucleotides having the sequence of a promoter of Kaposis sarcoma-associated herpesvirus latency-associated nuclear antigen 2 transcription. This invention also provides a method of inhibiting p53 mediated apoptosis of a cell and a method of producing an antibody which comprises introducing into a cell a replicable vector of the subject invention.

Spliced Gene Of Kshv/Hhv8, Its Promoter And Monoclonal Antibodies Specific For Lana2

US Patent:
6866854, Mar 15, 2005
Filed:
Sep 5, 2003
Appl. No.:
10/656499
Inventors:
Yuan Chang - Irvington NY, US
Patrick S. Moore - Irvington NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K039/245
US Classification:
4242291, 4241301, 435345, 435 71, 530300
Abstract:
This invention provides an isolated nucleic acid which encodes a Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 polypeptide (LANA2) or a fragment thereof and also provides the LANA2 polypeptide. This invention provides an isolated nucleic acid comprising consecutive nucleotides having the sequence of a promoter of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 transcription. This invention also provides a method of inhibiting p53 mediated apoptosis of a cell and a method of producing an antibody which comprises introducing into a cell a replicable vector of the subject invention.

Unique Associated Kaposi's Sarcoma Virus Sequences And Uses Thereof

US Patent:
7932066, Apr 26, 2011
Filed:
May 9, 2007
Appl. No.:
11/801641
Inventors:
Yuan Chang - New York NY, US
Patrick S. Moore - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C12N 9/00
C07K 5/00
US Classification:
435174, 530300
Abstract:
This invention provides an isolated peptide encoded by a nucleic acid which is at least 30 nucleotides in length and has a sequence which uniquely defines a herpesvirus associated with Kaposis' sarcoma, which herpesvirus is present in and recoverable from the HBL-6 cell line (ATCC Accession No. CRL 11762).

Analytics Information Directories Within A Comprehensive Framework For Composing And Executing Analytics Applications In Business Level Languages

US Patent:
2011006, Mar 17, 2011
Filed:
Sep 14, 2009
Appl. No.:
12/559399
Inventors:
Yuan Chi CHANG - Bayside NY, US
Manoj KUMAR - Yorktown Heights NY, US
Chung-Sheng Li - , US
Assignee:
INTERNATIONAL BUSINESS MACHINES CORPORATION - ARMONK NY
International Classification:
G06F 15/16
G06F 17/30
US Classification:
707600, 707821, 709231, 707E17005, 707E17009
Abstract:
Systems, methods and articles of manufacture are disclosed for building and executing analytics solutions. Such a solution may provide a comprehensive analytics solution (e.g., a risk assessment, fraud detection solution, dynamic operational risk evaluations, regulatory compliance assessments, etc.). The analytics solution may perform an analytics task using operational data distributed across a variety of independently created and governed data repositories in different departments of an organization. A framework is disclosed which allows a user (e.g., a risk analyst) to compose analytical tools that can access data from a variety of sources (both internal and external to an enterprise) and perform a variety of analytic functions.

Analytics Integration Workbench Within A Comprehensive Framework For Composing And Executing Analytics Applications In Business Level Languages

US Patent:
2011006, Mar 17, 2011
Filed:
Sep 14, 2009
Appl. No.:
12/559407
Inventors:
Yuan Chi CHANG - Bayside NY, US
Manoj KUMAR - Yorktown Heights NY, US
Chung-Sheng LI - , US
Assignee:
INTERNATIONAL BUSINESS MACHINES CORPORATION - Armonk NY
International Classification:
G06F 17/30
US Classification:
707602, 707E17005
Abstract:
Systems, methods and articles of manufacture are disclosed for building and executing analytics solutions. Such a solution may provide a comprehensive analytics solution (e.g., a risk assessment, fraud detection solution, dynamic operational risk evaluations, regulatory compliance assessments, etc.). The analytics solution may perform an analytics task using operational data distributed across a variety of independently created and governed data repositories in different departments of an organization. A framework is disclosed which allows a user (e.g., a risk analyst) to compose analytical tools that can access data from a variety of sources (both internal and external to an enterprise) and perform a variety of analytic functions.

Possible Relatives

Cynthia L Chang  David Chang  Dean A Chang  Deanna T Chang  Deborah Chang  Dana M Chang  Yuan Kohler  Yuan Li  Yuan Lin 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.